Facilitators and barriers to medication adherence among stroke survivors in India

被引:11
作者
Shani, S. D. [1 ]
Sylaja, P. N. [2 ]
Sarma, P. Sankara [1 ]
Kutty, V. Raman [3 ]
机构
[1] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Achutha Menon Ctr Hlth Sci Studies AMCHSS, Thiruvananthapuram, Kerala, India
[2] Sree Chitra Tirunal Inst Med Sci & Technol SCTIMS, Dept Neurol, Thiruvananthapuram 695011, Kerala, India
[3] Amala Canc Res Ctr, Trichur 680555, India
关键词
Medication adherence; Risk factor control; Stroke survivors; Life style; India; SECONDARY PREVENTION; ISCHEMIC-STROKE; RISK;
D O I
10.1016/j.jocn.2021.03.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strict compliance with medication and life style modification are integral to secondary stroke prevention. This study was undertaken to find out medication adherence among stroke survivors and factors associated with it. Cross sectional survey among stroke survivors was conducted. Interview based self-reported medication adherence was defined as consumption at least >80% of their medications for last two weeks, based on last prescription. Structured interview using pretested interview schedule was done to collect other data. Sequential step wise logistic regression analysis was done to find out the facilitators and barriers to medication adherence. Two hundred and forty stroke survivors (mean age 58.64 +/- 10.96 years; 25.4% females) with a mean post-stroke period of 6.65 +/- 3.36 months were participated. Overall medication adherence was 43.8% (n = 105). Medication adherence was 34.3% (n = 134), 52.6% (n = 190) and 56.7% (n = 224) for antidiabetics, antihypertensives and statins respectively and was associated with risk factor control (Diabetes: Odds Ratio (OR) = 4.85; 95% Confidence Interval (CI) 2.12-11.08, Hypertension: OR = 3.42; 95% CI 1.83-6.4, Dyslipidaemia: OR = 3.88; 95% CI 1.96-4.04). Having daily routine (OR = 2.82; 95% CI 1.52-5.25), perceived need of medication (OR = 2.33; 95% CI 1.04-5.2) and perceived poor state of health (OR = 2.65; 95% CI 1.30-5.40) were facilitators. Memory issues (OR = 0.34; 95% CI 0.16-0.71), side effects (OR = 0.24; 95% CI 0.11-0.42) and financial constraints (OR = 0.46; 95% CI 0.24-0.91) were barriers to medication adherence. Establishing daily routines, periodic reminders, financial supports to buy medicines and patient education can enhance medication adherence to prevent future strokes. (c) 2021 Elsevier Ltd. All rights reserved.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [31] mHealth App to improve medication adherence among older adult stroke survivors: Development and usability study
    Cao, Wenjing
    Wang, Juan
    Wang, Yuhui
    Hassan, Intan Idiana
    Kadir, Azidah Abdul
    [J]. DIGITAL HEALTH, 2024, 10
  • [32] Qualitative Analysis of Barriers and Facilitators to Glaucoma Medication Adherence in a Randomized Controlled Trial Intervention
    Rathinavelu, Jay K.
    Muir, Kelly W.
    Majette, Nadya T.
    Woolson, Sandra
    Olsen, Maren K.
    Flaharty, Kathryn
    Newman-Casey, Paula Anne
    Kirshner, Miriam
    [J]. OPHTHALMOLOGY GLAUCOMA, 2023, 6 (06): : 626 - 635
  • [33] Adherence to medication in stroke survivors: A qualitative comparison of low and high adherers
    Chambers, Julie A.
    O'Carroll, Ronan E.
    Hamilton, Barbara
    Whittaker, Jennifer
    Johnston, Marie
    Sudlow, Cathie
    Dennis, Martin
    [J]. BRITISH JOURNAL OF HEALTH PSYCHOLOGY, 2011, 16 : 592 - 609
  • [34] Personal experiences of electronic measurement of medication adherence in elderly stroke survivors
    Chambers J.A.
    O’Carroll R.E.
    Dennis M.
    Sudlow C.
    Johnston M.
    [J]. Drugs & Therapy Perspectives, 2015, 31 (5) : 167 - 174
  • [35] Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study
    Norberg, Helena
    Sjolander, Maria
    Glader, Eva-Lotta
    Gustafsson, Maria
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (05) : 869 - 877
  • [36] Adherence to Post-Stroke Pharmacotherapy: Scale Validation and Correlates among a Sample of Stroke Survivors
    Sakr, Fouad
    Dabbous, Mariam
    Akel, Marwan
    Salameh, Pascale
    Hosseini, Hassan
    [J]. MEDICINA-LITHUANIA, 2022, 58 (08):
  • [37] Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study
    Wells, Kristen J.
    Pan, Tonya M.
    Vazquez-Otero, Coralia
    Ung, Danielle
    Ustjanauskas, Amy E.
    Munoz, Dariana
    Laronga, Christine
    Roetzheim, Richard G.
    Goldenstein, Marissa
    Carrizosa, Claudia
    Nuhaily, Sumayah
    Johnson, Kenneth
    Norton, Marilyn
    Sims, Elizabeth
    Quinn, Gwendolyn P.
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (10) : 4123 - 4130
  • [38] Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study
    Kristen J. Wells
    Tonya M. Pan
    Coralia Vázquez-Otero
    Danielle Ung
    Amy E. Ustjanauskas
    Dariana Muñoz
    Christine Laronga
    Richard G. Roetzheim
    Marissa Goldenstein
    Claudia Carrizosa
    Sumayah Nuhaily
    Kenneth Johnson
    Marilyn Norton
    Elizabeth Sims
    Gwendolyn P. Quinn
    [J]. Supportive Care in Cancer, 2016, 24 : 4123 - 4130
  • [39] Barriers to medication adherence among adolescents and young adults with cancer
    McGrady, Meghan E.
    Ketterl, Tyler G.
    Norris, Robin E.
    Perentesis, John P.
    Pettee, Daniel
    Mara, Constance A.
    Breen, Gabriella
    Pai, Ahna L. H.
    [J]. PEDIATRIC BLOOD & CANCER, 2023, 70 (03)
  • [40] Using the theoretical domains framework to determine the barriers and facilitators to medication adherence in Parkinson's disease
    Smith, J. C.
    Seage, C. H.
    Lane, E.
    James, D. H.
    [J]. EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2023, 11